B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Deactivation of the beta-catenin transactivating complex

REACTOME PATHWAY
Reactome: R-HSA-37694029 genes22 compounds

The Deactivation of the beta-catenin transactivating complex pathway (Reactome ID: R-HSA-3769402) involves 9 genes and is affected by 22 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

ASH2LCTBP1DPY30HDAC1MEN1RBBP5TCF7L2WDR5XPO1

Compounds Affecting Deactivation of the beta-catenin transactivating complex

#CompoundTargets HitStudies
1s adenosylhomocysteine300
2Vorinostat299
3trichostatic acid [Supplementary Concept] related to trichostatin300
4scriptaid53
5Valproic Acid296
6pictilisib25
7Butyric Acid300
8Ursolic Acid300
9Celecoxib295
10Daunorubicin298
11Bortezomib300
12Camptothecin300
13NAD300
14NAD300
15NAD300
16Carmine Coloring matter from300
17Diiodotyrosine300
18plumbagin [Supplementary Concept]300
19oridonin300
20Tannins Polyphenolic compounds with molecular weights of around 500-3000 daltons and containing enough hydroxyl groups (1-2 per 100 MW) for effective cross linking of other compounds (ASTRINGENTS).300
21Nitroblue Tetrazolium Colorless to yellow dye that is reducible to blue or black formazan crystals by certain cells; formerly used to distinguish between nonbacterial and bacterial diseases,300
22pnu746546

About the Deactivation of the beta-catenin transactivating complex Pathway

The Deactivation of the beta-catenin transactivating complex pathway is catalogued in Reactome (ID: R-HSA-3769402) and involves 9 genes. In the BiohacksAI corpus, 22 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include ASH2L, CTBP1, DPY30, HDAC1, MEN1.